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ABSTRACT: Dispersion of oxolinic acid and occurrence of Aerornonas salmonicida in wild fauna were 
studied in animals captured in the vicinity of 2 aquaculture facilities during and after medication with 
this drug. Consumption of antibacterial agents in aquaculture has reached a considerable level. The 
major part of the drugs used reach the environment, either directly due to excessive feeding and 
reduced appetite of the cultured fish, or indirectly after having passed through the fish. Some of the 
drugs entering the environment are taken up by exploitable wild fish, shellfish and crustaceans, 
resulting in concentrations far above those accepted in food for human consumption in Norway. The 
concentration of oxolinic acid in muscle and liver was highest In pelagic flsh like coalfish and mackerel. 
The mean concentration in muscle of all positive samples at the day of medication termination were 
4.38 pg g-l and 0.42 pg g- '  at 2 different farms. Maximum concentration of oxolinic acid in muscle sam- 
ples was 12.51 pg g-' We found a simultaneous occurrence of oxolinic acid and the fish pathogenic 
bacterium A. salmonicida in the gut of both cultured and wild fish. This may lead to development and 
dispersion of resistant bacteria. Blue mussels Mytjlus edulis harvested at one of the farms contained an 
elevated level of bacteria resistant to oxolinic acid. 
Total 
-- ¤ Oxolinic acid 
INTRODUCTION titatively, none of these animals metabolised OA as 
humans. Qualitatively, however, rats, rabbits and dogs 
Bacterial diseases are considered a major problem in transformed oxolinic acid in a manner similar to that in 
fish farming. Even though much work has been done humans. The molecular structure of oxolinic acid is 
to prevent outbreaks of such diseases, considerable shown in Fig. 2. 
amounts of antibacterial substances are still pre- 
scribed. In Norway, oxytetracycline (OTC), furazoli- 
done (FZ) and tnmethoprim/sulfa drugs were for many 
years the substances of flrst choice. However, since 
1987 quinolones, especially oxolinic acid (OA), have 
found broader use (Fig. 1). In 1990 OA represented 
74% by weight of all antimicrobial drugs prescribed in 
the treatment of fish in Norwegian aquaculture (statis- 
tics provided by Norwegian Medicinal Depot, Oslo). 
Oxolinic acid (5-ethy1-5,8-dihydro-8-0~0-1,3-diox- 
olo(4,5-glquinoline-7-carboxylic acid) is a weak acid 
with pK, at 6.9. It is practically insoluble in acidic solu- 
tions but very soluble in alkaline media. In humans, 
OA is converted into at least 8 metabolites which are 
1987 1988 1989 1990 
Year 
excreted principally as glucuronides (DiCarlo et Fig. 1. Total amount of antibacterial agents and amount of 
1968). Crew et al. (1971) examined the metabolism of oxolinic acid used in Norwegian aquaculture in the years 
OA in rats, rabbits and dogs; they reported that, quan- 1987 1990- 
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Fig. 2. Molecular structure of oxol~nic acid 
Bacterial infections in fish are commonly treated 
using food pellets containing the desired antibacterial 
substance. However, diseased fish often show reduced 
appetite and an over-feeding may occur, leading to 
medicated food pellets entering the surro~ ndings 
During feeding, fragments containing the antibacterial 
agent may fall off, or the drug may be released from 
the pellet in a dissolved form (Higuera et al. 1990). 
Further, preliminary experiments using OA as the anti- 
bacterial agent have shown that some of the drug 
eaten by the farmed fish is excreted in an  unchanged 
active form via the urine or faeces (Samuelsen 
unpubl.). Hence, considerable amounts of the drug will 
enter the environment either directly due to over- 
feeding or indirectly after having passed through the 
animal under treatment. Therefore, during chemo- 
therapy of farmed fish, the wild fauna may be exposed 
to varying amounts of drugs, sometimes on several 
occasions during a year 
Particle-bound medicine can be taken up by filter- 
feeders such as appendicularians or mussels and dis- 
solved drugs can be absorbed by organisms directly 
from the water (Nusbaum & Shotts 1981). Using a 
microbiological method, Master (1986) found residues 
of OTC in blue mussels Mytilus edulis harvested 80 m 
from the application area. Medicated faeces and food 
pellets also reach the bottom deposits under the farms 
in considerable amounts (Jacobsen & Berglind 1988, 
Bjorklund et al. 1990, Samuelsen et al. in press). The 
occurrence of OTC in fish caught near a rearing facility 
for rainbow trout Oncorhynchus mykiss on the south- 
west coast of Finland was investigated by Bjorklund et 
al. (1990). 
They found OTC levels ranging from 0.2 to 1.3 pg g-' 
in 8 muscle samples of bleak Alburnus alburnus L. 
collected on the last day of medication. The medication 
regime applied was 100mg OTC (kgfish)-' d-' for l 0  d. 
They also found that roach Rutilus rutilus L., caught 
near a salmon farm 1 d after terminated medication, 
had OTC levels in muscle in concentrations close to the 
detection limit of the HPLC method (0.05 ,ug g-'). The 
farms described by Bjorklund were located in an area 
with brackish water of salinity ca 5%. Bleak and roach 
are typical species in brackish or freshwater fauna. In 
coastal areas of countries including Norway and Scot- 
land, coalfish Pollachius virens, cod Gadus morhua, 
mackerel Scorn ber scombrus, ballan wrasse La brus 
bergylta and haddock Melanogramrnus aeglefinus are 
the most common species found in the vicinity of 
marine aquaculture sites (Carss 1990). No findings 
concerning possible OA residues in the wild fauna 
near Norwegian salmon farms have yet been pub- 
lished. The present study was undertaken to obtain in- 
formation on the occurrence and concentrations of OA 
in the wild fauna in the vicinity of 2 salmon farms 
located on the west coast of Norway. The occurrence of 
the bacterium Aeromonas salmonicida in the gut con- 
tent of both farmed and wild fish and the number of 
bacteria resistant to OA in M. eduLis were also studied. 
A. salmonicida !S the causative agent of fnruncr?los:s, 
at present the most severe disease of bacterial origin in 
Norwegian aquaculture. 
MATERIALS AND METHODS 
Sampling sites. Samples of cultivated fish, wild fish, 
crabs and blue mussels were collected at 2 marine 
aquaculture facilities on the west coast of Norway 
during October and November 1990. On Farm 1, 
134 000 kg of salmon Salmo salar L. suffering from 
furunculosis were treated for 10 d using a total of 34 kg 
OA distributed in 11 200 kg moist pellets. This farm 
represents a typical Norwegian fish farm in size and 
stock. Average seawater temperature was 9 'C during 
the sampling period and the water depth under the 
cages varied between 40 and 70 m. The farm was 
located in a narrow strait with tidal currents in alter- 
nating directions. 
On Farm 2, 18 000 kg salmon suffering from vibriosis 
(Vibrio anguillarum) were treated for 8 d using a total 
of 9.84 kg OA distributed in 1.928 kg dry pellets. Aver- 
age seawater temperature was 11 "C during sampling 
and the water depth under the cages varied between 
30 and 60 m. 
Sampling. Samples were collected on the last day of 
medication (Day 0) at both farms and at Days 4 ,  7 and 
13 (Farm 1) and Days 7 and 13 (Farm 2) following 
medication. Wild fish weighing between 0.6 and 5 kg 
were caught using fishing lines or with nets placed 
within 400 m of the farms. Crabs were caught both in 
nets and traps, and blue mussels were collected with a 
landing net or by divers. Samples of muscle, liver and 
blood were taken from the fish immediately after the 
catch was landed. Haemolymph and muscle samples 
were collected from the crabs. Haemolymph and blood 
samples were taken using a heparinlzed 1 m1 syringe, 
centrifuged at 15000 X g on the farm using a Bio- 
fuge A centrifuge (Heraeus Sepatech, Osterode am 
Harz, Germany) keeping only the plasma fraction. A 
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total of 46 samples of gut contents were taken from 
wild and cultivated fish at Farm 1 during the sampling 
period. All samples were kept on ice in the dark. 
Samples of the gut contents and blue mussels used in 
the n~icrobiological assays were prepared and ana- 
lysed on the day of sampling, at once on return to the 
laboratory. This was also the case with the plasma 
samples analysed for OA residues using high-perfor- 
mance liquid chromatography (HPLC). For determina- 
tion of OA residues, the blue mussels, muscle samples 
from crabs and fish, and liver samples from fish were 
kept at -20 "C until analysed. 
Analysis. Plasma samples (100 p1) were analysed 
for OA residues following the method described by 
Samuelsen (1990). Standard curves for OA in the range 
0.01 to 1 and 1.0 to 2.5 kg ml-' were prepared using 
drug-free plasma of salmon, coalfish and crab. Flume- 
quine was used as internal standard in a concentration 
of 1.0 and 2.5 pg ml-' plasma respectively. 
The tissue samples were prepared for HPLC follow- 
ing the procedure of Samuelsen (1989) with minor 
modifications. Muscle (crabs and fish), liver (fish) and 
soft tissue homogenate (blue mussels) (1 g) from each 
organism were weighed, homogenized with two 20 m1 
portions of McIlvaine buffer (pH 3.6)-methanol (55-45) 
at high speed for 1 min and centrifuged for 10 min at 
8000 X g in a Sorvall RC-5B refrigerated superspeed 
centrifuge (Du Pont Instruments, Newtown, CT, USA). 
Prior to the first homogenization 0.1, 1.0 or 5.0 kg 
flumequine dissolved in 0.1M NaOH was added as an 
internal standard. The amount of internal standard 
added to the muscle and Liver samples were based 
upon the concentration of OA found in the correspond- 
ing plasma samples. 
The combined supernatants were filtered (589 Black 
ribbon, Schleicher & Schuell, Dassel, Germany) and 
evaporated under reduced pressure at a temperature 
of 40 "C until 15 m1 of the solution remained in the 
flask. Using 5 m1 McIlvaine buffer (pH 3.6) for wash- 
ing, the flask content was transferred to a separating 
funnel already containing 25 m1 of dichloromethane. 
After gently shaking the separating funnel for ca 
1 min, the 2 layers were allowed to separate and the 
dichloromethane fraction was transferred to a further 
separating funnel and rinsed with 10 m1 of McIlvaine 
buffer (pH 3.6). The dichloromethane phase containing 
the drugs was transferred to a small beaker and 
evaporated to dryness in a water-bath (40 "C) under a 
stream of nitrogen. The residue was dissolved in 0.25 
or 0.5 m1 of 0.1M NaOH and centrifuged for 5 min at 
15 000 X g (Biofuge A centrifuge). This solution (25 p1) 
was used for HPLC. 
Standard curves for OA in the range of 0.01 to 0.1, 
0.1 to 1.0 and 1.0 to 10 pg g- '  were prepared using 
drug-free samples of muscle (coalfish, crab and 
salmon), liver (coalfish, salmon) and homogenised soft 
tissue (blue mussel). Flumequine was used as internal 
standard in concentrations of 0.1, 1.0 and 5.0 pg g- '  
tissue respectively. Standard curves were drawn by 
plotting the known drug concentration against the 
ratio of drug to internal standard peak height. These 
curves were also used to calculate the detection limits. 
The extraction recoveries of OA and flumequine in 
plasma and tissues were determined by comparing 
peak heights from the analysis of samples spiked with 
1.0 pg g- '  OA and flumequine with peak heights 
resulting from direct injection of a standard. The chro- 
matographic assay and HPLC equipment described by 
Samuelsen (1990) was used to analyse both the tissues 
and plasma samples. 
Linear graphs (r = 0.97 to 0.99) were obtained for OA 
in plasma (0.01 to 2.5 pg ml-l), homogenised soft 
tissue, muscle and liver (0.01 to 10 pg g-l)  samples. 
Detection limits were calculated to be 0.003 to 0.010 
pg g-' with a signal to noise ratio of 3, and recoveries 
were between 85.4 and 93.5 % when blank samples ( l  g 
tissue, 100 p1 plasma) were spiked with 1.0 pg OA. 
Lowest recoveries and highest detection limits were 
obtained for the liver samples. The standard curves for 
coalfish were used to calculate the OA residues in all 
species except salmon, crab and blue mussel. 
The occurrence of 0.4 in the gut contents of fish and 
the soft tissue of blue mussels was examined using a 
standard microbiological method applying an OA- 
sensitive organism (Escherichia col1 B6). Aliquots of 
0.05 m1 of the sample material was applied on a thin 
lawn of bacteria on Petri dishes using a sterile plastic 
syringe. The media used was Luriua Bertani Agar, a 
standard medium for cultivation of E. col1 (Difco bacto 
agar 15 g,  Difco bacto tryptone 10 g ,  Difco yeast extract 
5 g,  glucose 1 g ,  NaCl 10 g, distilled water to 1 l ,  pH 
adjusted to 7.4). Results were read after incubation at 
37 "C for 12 h .  Inhibition zones in bacterial growth 
indicated the presence of antibacterial substances in 
the sample material. When applying this method, iden- 
tification of the agent in question cannot be done. 
However, it is not very likely that other substances 
either eaten or produced by the fish or produced by 
bacteria in the gut would give inhibition zones of the 
magnitude observed here. In this study we therefore 
consider growth inhibition of E. coli as a positive result 
for the occurrence of OA in the gut. 
To quantify the number of OA resistant bacteria 
associated with the soft parts of the blue mussels a 
homogenate was plated on agar media containing 
10 pg ml-' OA. The number of colony forming bacteria 
on the media containing OA was compared to the 
number of bacteria growing on media without any 
antibacterial agent, indicating the percentage of 
bacteria resistant to OA in blue mussels. The media 
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Table l Residues of oxolinlc a c ~ d  in plasma, muscle and liver, total count of bacteria and the occurrence of Aerornonas salrno- 
nicida in faeces from wild fish and farmed salmon at Farm 1 Day: days following medication; Farm: samples taken from salmon 
ins~de  the cages; 0, 50 and 100 m: distance from the farm; n: total number of samples examined Coalf~sh - Polldchius virens, 
salmon = Salmo salar. Activity: number of samples containing faecal material with antibacterial activity; A salm.: number of 
samples contaming A. salmoniada in faeces; total count: total number of bacteria per m1 faeces 
I Day Location n Species Mean concentrations ~n pg g-' Faeces I 
Farm 
0 m 
Farm 
0 m 
Farm 
0 m 
50 m 
100 m 
Farm 1:: o m  
I na: not analysed 
Salmon 
Coalfish 
Salmon 
Coalfish 
Salmon 
Salmon 
Salmon 
Salmon 
Salmon 
Coalfish 
Muscle 
0.7 
5.99 
0.49 
3.92 
0.06 
0.00 
0.23 
0.91 
Liver 
0 4 
7.66 
0.33 
2.47 
0.04 
0.00 
0.47 
L7 02 
Plasma 
0.08 
1.50 
0.16 
0.69 
0.06 
0.00 
0.18 
3.C3 
Activity A. salm. Total count 
3.0 X log 
7.4 X 109 
na 
na 
2.7 X 10' 
2.6 X log 
1.2 X 109 
i . 7  A io" 
used was tryptone soya agar (TSA) in 70 % seawater as microscope with a HBO 50 W mercury lamp and a 
recommended by Lunestad & G o k s ~ y r  (1990) for deter- DAPI/FITC filter package as described by Enger et al. 
mination of resistance of marine bacteria (tryptone (1989). Immunofluorescent positive cells with a halo 
soya broth 20 g,  Difco bacto agar 15 g, 70 % seawater were only registered as positive counts of A. salrno- 
to 1 1). The plates were read after 3 d following aerobic nlcida if the bacteria also exhibited a positive DAPI 
incubation at  15 "C. signal. 
To determine the total number of bacteria and the 
number of Aeromonas salmonicida in the faeces of fish 
and blue mussel homogenate, each sample was homo- RESULTS 
genized for 1 min in a Waring blendor at low speed and 
diluted 1:1000 in prefiltered seawater. The samples A total of 46 wild fish and farmed salmon samples 
were preserved with formaldehyde (final concentra- from Farm 1 were analysed for faecal antibacterial 
tion 2 %) and the bacteria were stained using the tech- activity, total number of bacteria and the presence of 
niques described by Hoff (1988) and Enger et al. Aeromonas salmonicida in faeces (Table 1). At Day 0, 
(1989). These methods involve filtration of the sample A. salmonicida was found in all of the 4 farmed salmon 
through a 0.2 pm Nucleopore filter and a staining while none of the 8 coalfish tested were positive. 
of the bacteria with 4,6-diamidino-2-phenylindole Neither the farmed salmon nor the coalfish tested at 
(DAPI). When applying this method, DAPI diffuses Day 4 contained A. salmonicida in the gut. However, 
from an underlying supporting filter previously soaked 7 d after termination of medication we found A. salmo- 
in DAPI solution (100 pg ml-l), staining the bacterial nicida in 2 out of 6 farmed salmon and in all 3 salmon 
DNA. The bacteria present on the Nucleopore fllter caught at a distance of 0 to 100 m from the farm. On the 
were also treated with monoclonal antibodies directed 12th day, A. salrnonicida was found both in the farmed 
towards A. salmonicida. The antibodies used were salmon and in 1 out of 7 coalfish. 
diluted 1:800 in marine PBS (20 g NaCl and 4.3 g High concentrations of OA in plasma, liver and 
MgC12- 6 H 2 0  in 1000 m1 distilled water adjusted to muscle were found at both Days 0 and 4 in pelagic 
pH 7.2) containing 0.5 % bovine serum albumin species (coalfish and mackerel) as well as in demersal 
(Sigma Chemical Company, St. Louis, MO, USA). After species (haddock and crabs). L~ver samples from wild 
50 min the filters carrying the bacteria were washed fish generally had higher residual OA concentrat~ons 
(3x) with aliquots of 3 ml marine PBS. One m1 of com- at Day 0 compared to muscle samples, but this dif- 
mercial FITC-conjugated rabbit anti-mouse immuno- ference had leveled out by Day 4 .  OA concentrations, 
globulin (DAkO, diluted 1 5 0 0  in marine PBS) was particularly in coalfish, were considerably higher 
added and the filters kept at room temperature for than in the farmed salmon tested at Days 0 and 4 
30 min. The filters were washed twice with marlne (Tables 2 & 3) .  
PBS before mounting on glass slides. The preparations Fig. 3 shows the total catch of wild fish and crabs at 
were examined in a Zeiss standard fluorescence Farms 1 and 2 and the number of OA-positive samples. 
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Table 2 Residues of oxolinic acid (pg g-l) in wild fauna in the vicinity of Farm 1. n: total number of samples (in parentheses) and 
number of positive plasma, muscle, liver and homogenate samples. Mean: mean value of all positive samples; max: maximum 
concentration found. Coalfish = Pollachius wrens, ballan wrasse = Labrus berggylta, ling = Molva molva, crab = Cancerpagurus, 
haddock = ~Melanogrammus aeglefinus, cod = Gadus morhua, pollack = Pollachius pollachius, salmon = Salnio salar, blue 
mussel = Myhlus eduljs 
Source of sample Day 0 Day 4 Day 7 Day l 3  
n Mean Max n Mean Max n Mean Max n Mean Max 
Coalfish (33) (13) (14) (18) 
Plasma 33 1.56 7.12 13 0.99 3.11 10 0.16 0.65 2 0.03 0.04 
Muscle 33 5.19 10.71 13 3.92 12.51 14 0.22 0.81 14 0.02 0.03 
Liver 33 6.45 13.59 13 3.65 14.68 14 0.21 0.87 12 0.02 0.03 
Ballan wrasse (2) (10) (6) (3) 
Plasnla 2 0.01 0.19 6 0.04 0.15 3 0.04 0.07 0 - - 
Muscle 2 0.49 0.92 10 0.44 1.37 5 0.03 0.08 0 - - 
Liver 2 0.29 0.37 10 0.34 0.90 5 0 04 0.10 0 - - 
Ling (3)  * (1) 
Plasma ns - - - - - - - - - - 
 muscle 3 0.63 1.26 - - - - - - 0 - - 
Liver 3 0.89 1.49 - - - - - - 0 - - 
Haddock (2) (1) * (1 
Plasma ns - - 1 0.52 - - - - 0 - - 
Muscle 2 5.02 8.99 1 1.88 - - 1 0.01 0.01 
Liver 2 5.21 9.21 1 0.72 - - - 1 0.01 0.01 
Salmon * * 
- - - 
(3) (2) 
Plasma ns - p ns - - 
Muscle - - - - - 2 0.12 0.23 1 0.1 0.1 
Liver - - - - 2 0.30 0.47 1 0.06 0.06 
Cod and pollack (2) (8)  (4) (8) 
Plasma 2 0.05 0.09 7 0.03 0.05 4 0.03 0 06 0 - - 
Muscle 2 0.42 0.62 7 0.10 0.37 4 0.02 0 03 3 0.02 0.02 
Liver 2 0.23 0.35 7 0.11 0.30 4 0.08 0.25 3 0.01 0.01 
Blue mussels (5) (5) (3) - 
Homogenate 5 0.65 1.48 3 0.05 0.09 0 - - - - - 
Crab (51 (13) (10) (12) 
Haemolymph 3 0.13 0.22 12 0.19 1.23 6 0.19 0.77 2 0.03 0.04 
Muscle 5 0.81 3.77 11 0.45 1.61 6 0.08 0.25 4 0.03 0.09 
* No catch; ns: no sample available 
In this investigation a positive sample was defined 
as one having a residual OA concentration exceeding 
10 ng g-l tissue or 10 ng ml-' plasma. Considering the 
large number of plasma samples on Day 7 at Farm 2 
having no residual OA, we found it unnecessary to 
analyse the muscle and liver samples. 
One sample (1 g) of homogenised tissue from 15 blue 
mussels collected on Farm 2 (Day 0) contained 0.07 pg 
g-' of OA and had levels of OA-resistant bacteria more 
than 10 times higher than those found in similar sam- 
ples from blue mussels collected 200 and 400 m away. 
The blue mussels collected at  200 and 400 m had no 
detectable OA residues. At Day 7, blue mussels collec- 
ted at Farm 2 contained no OA and had levels of OA- 
resistant bacteria similar to the mussels from 200 and 
400 m (Day 0). 
DISCUSSION 
Oxolinic acid (OA) was first described in 1968 
(Kaminsky & Meltzer 1968). OA inhibits microbial 
growth by interfering with DNA gyrase activity and is 
effective on Gram-negative bacteria (Wolfson et al. 
1989). Gram-positive bacteria and anaerobes are 
usually not susceptible to OA (Walter & Heilmeyer 
1975, Wolfson et al. 1989). Single step mutations 
leading to high-level resistance towards OA in bac- 
teria have been reported to occur with frequencies in 
the range 10-6 to 10-'. This creates the possibility of 
emergence of resistant organisms during therapy 
(Wolfson et al. 1989). On the other hand there have 
been no descriptions of transferable or plasmid- 
mediated resistance towards OA (Wolfson et al. 1989). 
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Table 3. Residues of oxolinic acid (pg g.') in wild fauna in the vicinity of Farm 2. n: total number of samples (in parentheses) and 
number of positive plasma, muscle and liver samples. Mean. mean value of all positive samples, max: maxlrnum concentration 
found. Coalfish = Pollachius virens, crab = Cancerpagurus, cod = Gadus morhua, haddock = Melanogrammus aeglefinus, pollack 
= Pollachiuspollachius, salmon = Salmo salar, flounder = Platichthys flesus, mackerel = Scomber scombrus 
Source of sample Day 0 Day 7 Day 13 
n Mean Max n Mean Max n Mean Max 
Coalfish 
Plasma 
Muscle 
Liver 
Mackerel 
Plasma 
Muscle 
Liver 
Cad 
Plasma 
Muscle 
Liver 
Pollack 
Plasma 
Muscle 
Liver 
Salmon 
Plasma 
Muscle 
Liver 
Flounder 
Plasma 
Muscle 
Liver 
Crab 
Haemolymph 
Muscle 
* No catch; na = not analysed 
Total number of samples at Farm 1 
Number of positive samples at Farm 1 
H Total number of samples at Farm 2 
Number of positive samples at Farm 2 
Fig 3. Total number of samples and number of positive 
muscle samples at Farms 1 and 2. Number of positive sam- 
ples at Farm 2, Day 7, are based on results from the plasma 
analysis 
High doses of OA in fish have been reported to cause 
haematological disturbances and adverse effects on 
liver (Miyazaki et al. 1984). 
In higher animals, OA is associated with toxic effects 
on the central nervous system (CNS) and with gastro- 
intestinal irritation (Goldberg et al. 1961, Walter & 
Heilrneyer 1975, Mandel & Sande 1985, Crumplin 
1988). Furthermore, OA is suspected to interfere with 
gene transcription in mammalian cells (Crumplin 
1988). Due to the relatively high incidence of adverse 
effects and the narrow spectrum of activity, OA has 
never been considered a first Line antimicrobial agent 
in clinical practice. However, the newer quinolones are 
promising. The incidence of adverse effects with the 
third generation quinolones seems to be reduced and 
the spectrum of activity has been broadened, making 
the new compounds more attractive for the treatment 
of bacterial diseases in humans (Moellering 1989). 
In this investigation we examined a total of 225 fish, 
76 crabs and 30 samples of blue mussels. Residues of 
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OA were detected in coalfish, mackerel, cod, haddock, 
whiting, ling, pollack, ballan wrasse, wild salmon, 
crabs and blue mussels. On the day medication was 
terminated the average concentration of OA in posltive 
muscle samples of wild fish was 4.38 pg g- '  at Farm l 
and 0.42 yg g- '  at Farm 2 .  The highest concentration of 
OA in n~uscle (12.51 yg g-l) was found in a coalfish 
caught at Farm 1 on Day 0. Even in fish caught 400 m 
away from Farm 1 at a depth of nearly 100 m, residues 
were found. These findings exceed by far the drug 
concentrations allowable in food for human consump- 
tion in many countries, including Norway. These coun- 
tries have general regulations requiring the complete 
absence of drug residues in food. Thus, in practice, the 
detection limit of the method employed is then the 
maximum level permitted. At present the detection 
limit of the microbiological test in use in Norway is 
0.10 pg g-' [H. Evensen (Directorate of Fisheries, Con- 
trol laboratory) pers. comm.]. The detection limits of 
the different HPLC methods available are 0.0005 to 
0.010 pg g- '  (Bjerrklund 1989, Rogstad et al. 1989, An- 
dresen & Rasmussen 1990, Steffenak et al. 1991). 
Twelve days after termination of medication, only 
minor concentrations of OA could be found in the 
tissues of the species examined. The farmed salmon 
contained much lower concentrations of OA than most 
of the wild living fishes. This reflects the usually low 
appetite of diseased fish. 
A considerable number of the fish examined had 
high concentrations of OA in the gut at Day 0 and 4. It 
is not yet known whether the high antibacterial 
activity is due to residues of drug from food intake or to 
excreted OA and microbiologically cleaved OA- 
conj.ugates from the bile. However, HPLC analysis of 
samples collected from salmon treated with OA 
showed residues of both unchanged and conjugated 
OA in the bile (Samuelsen unpubl.). It is possible for 
drug conjugates in the bile to be transformed to active 
drug by the intestinal bacteria and then reabsorbed 
(enterohepatic circulation). Four other fish farms were 
situated in the same area as Farm 1. In these farms, a 
total of 660 tonnes of salmon were treated with OA 
during the same period as treatment at  Farm 1. This 
may partly account for the high residues of OA in the 
fish and large number of positive samples at  Farm 1. 
When OA was detected in the intestinal contents, the 
inhibition zones produced varied between 12 and 
30 mm in diameter. Fish containing OA in faeces 
usually had high concentrations of the drug in liver, 
muscle and plasma. Considering the positive correla- 
tion with the HPLC method, the microbiological assay 
could be valuable in the investigation of drug residues 
in both farmed and wild organisms since the microbio- 
logical method is rapid and does not require expensive 
equipment. 
Several authors reported an increase in the number 
of resistant faecal bacteria during antibacterial treat- 
ment in humans (Goldberg et al. 1961, Datta et al. 1971). 
This has also been reported to occur in the treatment 
of fish (Aoki et al. 1972, Toranzo et al. 1984, Schlotfeldt 
et al. 1985). In previous years an increase in the occur- 
rence of the pathogenic fish bacteria Aeromonas salmo- 
nicida and Yersin~a ruckeri (causal agent of enteric red- 
mouth disease) resistant to OA has been reported 
(Hastings & McKay 1987, O'Grady et al. 1987, Tsoumas 
et  al. 1989). It is therefore reasonable to believe that 
this decrease in susceptibility is caused by the wide- 
spread use of OA in the treatment. On the other hand 
Sugita et  al. (1989) reported that OA did not markedly 
influence the number of bacteria, the bacterial ability 
to resist OA and the intestinal bacterial flora of gold- 
fish Carassius auratus during a standard treatment. 
Aerornonas salrnonicida and OA were present sim- 
ultaneously in the gut of wild and farmed salmon 
(Table 1). This may permit A. salrnonicida to develop 
resistance towards OA and, via faeces, be spread to the 
environment. In this manner furunculosis can be 
spread to the wild fish population and further to other 
fish farms by OA resistant bacteria. 
Marine bivalves have frequently been employed in 
the assessment of environmental pollution. Their wide 
distribution and low level of xenobiotic metabolism 
combined with a sessile adult behavior and high filter 
activity makes these organisms especially suitable for 
the detection of pollutants (Krieger et al. 1981). In our 
investigation we found low to moderate concentrations 
of OA in the blue mussels examined. Despite low 
concentrations of OA in blue mussels at Farm 2,  an 
increased percentage of OA-resistant bacteria could 
be observed in samples taken immediately after termi- 
nation of medication. One explanation may be that the 
mussels have filtered out resistant bacteria shed from 
the intestine of fish receiving the drug. At low pump- 
ing rates blue mussels have been reported to be 
capable of retaining particles as small as 2 pm. At high 
pumping rates all particles larger than 6 pm are 
retained (Dral 1967, Vahl 1972). However, most marine 
bacteria are too small to be retained efficiently by blue 
mussels if not aggregated or present on debris (Wright 
et al. 1982). Some of the bacteria in the intestine of fish 
may well be associated with faecal particles which are 
filterable by blue mussels. Bacteria found on soft tissue 
surfaces of blue mussels at  Day 7 after termination of 
medication had no elevated level of bacteria resistant 
to OA. There is reason to believe that the bacterial 
flora of blue mussels reflects the flora present in the 
water. When the concentration of OA in the farmed 
and wild fish intestine decreases, the number of 
resistant bacteria released into the seawater will also 
decrease. 
l l b  dis .  aquat. Org. 1 
Since it is a well established principle that residues 
of medicines given to livestock animals should not be 
found in food for human consumption, considerable 
efforts are made to prevent drug transfer in this way. 
However, the present investigation clearly shows that 
during medication the wild fauna near a fish farm is 
exposed to the drug in use. If wild fish, crustaceans or 
mussels are harvested in the vicinity of an aquaculture 
facility during medication, the risk of drugs reaching 
consumers is high. In the case of OA, the drug is also 
rather thermostable and no reduction in antibacterial 
activity could be observed when an aqueous solution 
of the drug was boiled for 15 min to simulate conditions 
resembling normal treatment of fish. 
Combined with a compulsory announcement of 
medication, collection of medicated food particles that 
fall through the net pens and optimisation of the medi- 
cation strategy will reduce the problem. Since there is 
no obvious reason to distinguish between free-living 
and farmed animals in regard to drug residues, moni- 
toring of exploitable wild animals exposed to drugs 
from aquaculture, similar to that with farmed fish, 
should be considered. 
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